title: Hepatic conversion of amino-nitrogen to urea in thyroid diseases. II. A study in hyperthyroid patients.
abstract: Conflicting data have been reported on the influence of thyroid hormones on hepatic nitrogen metabolism and on liver metabolic activity. We studied the urea-nitrogen synthesis rate (UNSR) and the kinetics of the process of hepatic amino-nitrogen to urea-nitrogen conversion in response to constant alanine infusion (ie, the functional hepatic nitrogen clearance [FHNC]) in five hyperthyroid female patients before and after the achievement of a stable euthyroid status. In the same patients, galactose elimination capacity and antipyrine clearance were also measured as quantitative indices of hepatic function. The basal urea synthesis rate was nearly doubled in hyperthyroid patients (35.6 +/- 8.5 mmol.h-1 v 17.6 +/- 7.7 in euthyroid patients, P < .05) and increased linearly with increasing alpha-amino-nitrogen (alpha-AN) concentrations in both conditions. The urea synthesis rate during alanine infusion was still higher by approximately 30 mmol.h-1 in hyperthyroid subjects. The FHNC, calculated as the slope of the linear relation between the UNSR in each time interval and the corresponding average alpha-AN concentration, was not different (hyperthyroidism, 30.6 +/- 7.2 L.h-1; euthyroidism, 28.5 +/- 4.4; normal values > 25). The hepatic microsomal and cytosolic activities (antipyrine clearance and galactose elimination) were normal in hyperthyroid patients and did not change significantly after therapy. Our data show that the hepatic nitrogen metabolism of hyperthyroid patients is characterized by an upregulation of amino-nitrogen catabolism and loss of the sparing mechanism at low plasma amino acid levels, without any change in different metabolic activities.
authors.affiliation: Istituto di Clinica Medica Generale e Terapia Medica, Università di Bologna, Italy.
authors.forename: G
authors.initials: G
authors.lastname: Marchesini
authors.forename: A
authors.initials: A
authors.lastname: Fabbri
authors.forename: G P
authors.initials: GP
authors.lastname: Bianchi
authors.forename: E
authors.initials: E
authors.lastname: Motta
authors.forename: P
authors.initials: P
authors.lastname: Giovanelli
authors.forename: D
authors.initials: D
authors.lastname: Urbini
authors.forename: A
authors.initials: A
authors.lastname: Lodi
mesh_terms: D000328:Adult; D000368:Aged; D000409:Alanine / Q000008:administration & dosage; D000596:Amino Acids / Q000378:metabolism*; D005260:Female; D006111:Graves Disease / Q000378:metabolism; D006801:Humans; D006980:Hyperthyroidism / Q000378:metabolism*; D008099:Liver / Q000378:metabolism*; D008875:Middle Aged; D009584:Nitrogen / Q000378:metabolism*; D013997:Time Factors; D015854:Up-Regulation; D014508:Urea / Q000378:metabolism*
chemical_list: D000596:Amino Acids; D014508:Urea; D009584:Nitrogen; D000409:Alanine